Richard A. Young - 11 Sep 2025 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Director
Signature
/s/ Josh Mandel-Brehm, as Attorney-in-Fact
Issuer symbol
CAMP
Transactions as of
11 Sep 2025
Net transactions value
+$24,999
Form type
4
Filing time
11 Sep 2025, 16:22:32 UTC
Previous filing
27 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Young Richard A Director C/O CAMP4 THERAPEUTICS CORPORATION, ONE KENDALL SQ., BLDG 1400 WEST, 3RD FL., CAMBRIDGE /s/ Josh Mandel-Brehm, as Attorney-in-Fact 11 Sep 2025 0001490283

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAMP Common Stock Purchase $24,999 +15,151 +9.8% $1.65 170,010 11 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 11, 2025, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share.